01 12MERCK SHARP DOHME
02 4SALERNO PHARMS
01 67326708
02 29597289
03 210300041
04 67326708*PED
01 6Y
02 10Blank
01 10Y
02 6Blank
01 62026-04-11
02 62026-10-11
03 22027-04-26
04 22030-02-23
Patent Expiration Date : 2026-04-11
SIMVASTATIN; SITAGLIPTIN PHOSPHATE
US Patent Number : 7326708
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202343
Patent Use Code : U-1188
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2026-04-11
Patent Expiration Date : 2026-04-11
SIMVASTATIN; SITAGLIPTIN PHOSPHATE
US Patent Number : 7326708
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202343
Patent Use Code : U-1188
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2026-04-11
Patent Expiration Date : 2026-04-11
SIMVASTATIN; SITAGLIPTIN PHOSPHATE
US Patent Number : 7326708
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202343
Patent Use Code : U-1188
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2026-04-11
Patent Expiration Date : 2026-04-11
SIMVASTATIN; SITAGLIPTIN PHOSPHATE
US Patent Number : 7326708
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202343
Patent Use Code : U-1188
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2026-04-11
Patent Expiration Date : 2026-04-11
SIMVASTATIN; SITAGLIPTIN PHOSPHATE
US Patent Number : 7326708
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202343
Patent Use Code : U-1188
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2026-04-11
Patent Expiration Date : 2026-04-11
SIMVASTATIN; SITAGLIPTIN PHOSPHATE
US Patent Number : 7326708
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202343
Patent Use Code : U-1188
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2026-04-11
Patent Expiration Date : 2026-10-11
SIMVASTATIN; SITAGLIPTIN PHOSPHATE
US Patent Number : 7326708*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 202343
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-10-11
Patent Expiration Date : 2026-10-11
SIMVASTATIN; SITAGLIPTIN PHOSPHATE
US Patent Number : 7326708*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 202343
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-10-11
Patent Expiration Date : 2026-10-11
SIMVASTATIN; SITAGLIPTIN PHOSPHATE
US Patent Number : 7326708*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 202343
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-10-11
Patent Expiration Date : 2026-10-11
SIMVASTATIN; SITAGLIPTIN PHOSPHATE
US Patent Number : 7326708*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 202343
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-10-11
LOOKING FOR A SUPPLIER?
Market Place
